These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6515960)

  • 1. [Reduction in thrombocyte volume and thrombocyte count in liver disease].
    Jørgensen BB; Fischer E; Ingeberg S; Hollaender N; Ring-Larsen H; Henriksen JH
    Ugeskr Laeger; 1984 Oct; 146(42):3198-201. PubMed ID: 6515960
    [No Abstract]   [Full Text] [Related]  

  • 2. [Corelations between thrombocyte count, clinical diagnosis, and liver pathology in chronic liver diseases].
    von Braun HH; Henning H; Lüders CJ; Probst P
    Z Gastroenterol; 1976 Sep; 14(5):538-47. PubMed ID: 969786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombocytopenia in hepatitis-B-antigenemia (author's transl)].
    Braun HH; Henning H; Probst P
    Med Klin; 1976 Jun; 71(23):1010-5. PubMed ID: 933994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum triglycerides in chronic hepatopathies].
    Coniglio S; Marchetti L; Torchio G; Colombo E; Gaido A; Giorgi S
    G Clin Med; 1979 Jul; 60(7):515-8. PubMed ID: 548290
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adenohypophyseal hormones in chronic liver diseases].
    Shlimovich PB
    Klin Med (Mosk); 1979 Jun; 57(6):70-6. PubMed ID: 459387
    [No Abstract]   [Full Text] [Related]  

  • 7. M-components in patients with chronic liver disease.
    Ellman LL; Pachas WN; Pinals RS; Bloch KJ
    Gastroenterology; 1969 Aug; 57(2):138-42. PubMed ID: 5799671
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases].
    Rostomova LT; Kurashvili RB
    Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Erythrocyte life span in certain hepatolienal diseases].
    Sokolova GM
    Klin Med (Mosk); 1972 Nov; 50(11):119-23. PubMed ID: 4666692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fasting and postprandial serum bile acids in chronic liver diseases].
    Testa R; Dellepiane F; Rovida S; Lapertosa G; Domina AR; Virdis MG; Risso D; Mansi C; Picciotto A; Savarino V; Celle G
    Minerva Dietol Gastroenterol; 1982; 28(3):195-200. PubMed ID: 7145170
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complement activity in chronic liver diseases].
    Ghidini O; Del Campo A; Tomasi A; Franzoni A
    G Clin Med; 1970 Jul; 51(7):568-79. PubMed ID: 5527274
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chromatographic determination of plasma and erythrocyte phospholipids in a group of patients with liver diseases].
    Ferlito S; Fichera C; Terranova R
    Minerva Gastroenterol; 1973; 19(4):207-15. PubMed ID: 4781112
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of hyperammonemia in liver diseases with special reference to neomycin].
    Gniwotta E; Neumann-Mangold P; Schalm J
    Z Allgemeinmed; 1974 Feb; 50(4):188-91. PubMed ID: 4824471
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study of the abnormalities of HDL (high density lipoproteins) in liver diseases].
    Inoue M
    Fukuoka Igaku Zasshi; 1985 Aug; 76(8):407-15. PubMed ID: 4065805
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic value of serum bile acids in chronic diseases of the liver].
    Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
    Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the action of C-reactive proteins in relation to current liver tests].
    Renger F; Kanehl R; Kanehl E
    Acta Hepatosplenol; 1965; 12(6):337-51. PubMed ID: 5868476
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasmatic angiotensinase activity in subjects with hepatic diseases of various types].
    Morandini G; Dimich D; Manca P; Spanedda M
    Minerva Med; 1967 May; 58(40):1876-81. PubMed ID: 4290743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies on the electrophoretic behavior of serum proteins various verified liver diseases of 913 patients].
    Fuchs T; Immich H
    Med Welt; 1970 Apr; 14():599-610. PubMed ID: 5450308
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
    Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
    Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.